help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrews, Z. B.
Right arrow Articles by Grattan, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrews, Z. B.
Right arrow Articles by Grattan, D. R.
Endocrinology Vol. 142, No. 6 2719-2724
Copyright © 2001 by The Endocrine Society


ARTICLES

Dissociation of Prolactin Secretion from Tuberoinfundibular Dopamine Activity in Late Pregnant Rats1

Zane B. Andrews, Ilona C. Kokay and David R. Grattan

Department of Anatomy and Structural Biology and Neuroscience Research Center, University of Otago School of Medical Sciences, Dunedin, New Zealand

Address all correspondence and requests for reprints to: Dr. David Grattan, Department of Anatomy and Structural Biology, University of Otago School of Medical Sciences, P.O. Box 913, Dunedin, New Zealand. E-mail: david.grattan{at}stonebow.otago.ac.nz


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This study investigated whether the PRL surge that precedes parturition is accompanied by a decrease in activity of hypothalamic tuberoinfundibular dopamine (TIDA) neurons, as occurs during the PRL surges of early pregnancy. Serial blood samples were collected at regular intervals during early and late pregnancy via chronic indwelling jugular cannulae, and concentrations of plasma PRL were determined by RIA. In addition, pregnant rats were killed at either 1200 and 0300 h on different days throughout pregnancy. Levels of TIDA neuronal activity were estimated using concentrations of 3,4-dihydroxyphenylacetic acid (DOPAC) in the median eminence as an index of dopamine metabolism. During early pregnancy, plasma PRL concentrations showed characteristic diurnal and nocturnal surges peaking at 1700 and 0300 h, respectively, whereas during late pregnancy, there was a broad nocturnal surge throughout the night preceding parturition. During early pregnancy, DOPAC was elevated at 1200 h, associated with suppressed plasma PRL, whereas at 0300 h, during the nocturnal PRL surge, DOPAC was significantly reduced (P < 0.05). On the last day of pregnancy DOPAC levels were significantly reduced at both 1200 and 0300 h compared with those at 1200 h in early pregnancy regardless of the PRL concentration. This experiment was repeated with additional groups to further characterize the timing of the fall in TIDA activity during late pregnancy. DOPAC concentrations were elevated throughout the second half of pregnancy, then fell significantly between 0300–1200 h on day 21, approximately 36 h before parturition. As in the previous experiment, the timing of changes in DOPAC concentrations in the median eminence was dissociated from the antepartum PRL surge. These data indicate that the regulation of PRL secretion during late pregnancy is different from that of early pregnancy. Despite the prolonged reduction in activity of TIDA neurons during late pregnancy, PRL secretion still occurs as a nocturnal surge, suggesting that dopamine is not the only regulator of PRL secretion at this time.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE SECRETION of PRL from the anterior pituitary gland is predominantly under inhibitory control from the hypothalamus. The major hypothalamic hormone responsible for this inhibition is dopamine, released from the tuberoinfundibular dopaminergic (TIDA) neurons located in the arcuate nucleus, with nerve terminals in the median eminence (1). Dopamine released from these neurons is transported to the pituitary gland via the hypophyseal long portal vessels. In addition, the periventricular hypophyseal and tuberohypophyseal dopaminergic neurons contribute to the regulation of PRL secretion (2). Dopamine from these neurons is released in the intermediate and neural lobes of the pituitary, respectively, and reaches the anterior pituitary by means of the short portal vessels. Dopamine activates D2 dopamine receptors on lactotrophs to tonically inhibit the release of PRL. In turn, PRL feeds back to stimulate the activity of all three populations of neuroendocrine dopaminergic neurons in the hypothalamus (2), presumably acting through PRL receptors expressed directly on these dopamine neurons (3, 4, 5). In this manner PRL can regulate its own release, a process known as short-loop negative feedback.

During early pregnancy in rats, PRL secretion occurs in a semicircadian rhythm, which is characterized by a large nocturnal surge and a slightly smaller diurnal surge (6, 7, 8). Both of these surges are necessary for the initiation and maintenance of luteal function (9). During this time TIDA neurons exhibit a daily pattern of activity that is inversely related to PRL secretion. Dopamine levels in the portal blood (10), tyrosine hydroxylase activity in the median eminence (8, 11, 12), and expression of Fos-related antigens in neuroendocrine dopaminergic neurons (13) are all reduced during the PRL surges and elevated in the intersurge interval when PRL is low. These PRL surges begin to reduce in magnitude on day 8 of pregnancy and are completely inhibited by day 10 of pregnancy (7, 14). The reduction in PRL surges during midpregnancy coincides with the onset of placental lactogen secretion, which inhibits PRL secretion from the maternal pituitary gland (15, 16, 17, 18) and replaces PRL as the major luteotropic factor in mid- and late pregnancy. As placental lactogen has a high degree of structural homology with PRL (19), the increased secretion of placental lactogen at midpregnancy mimics the negative feedback action of PRL to produce chronic stimulation of the TIDA neurons (2, 18, 20). This increase in TIDA activity is responsible for terminating maternal PRL secretion (16) and maintaining low levels of PRL throughout the second half of pregnancy (2, 21).

During late pregnancy, plasma PRL levels remain low until a large PRL surge occurs during the dark period immediately preceding parturition (22). The magnitude and timing of this antepartum surge are similar to the nocturnal surges of early pregnancy, except that the antepartum PRL surge is much broader (22, 23). Although plasma placental lactogen begins to decline slightly during late pregnancy (24, 25), placental lactogen levels remain relatively high at the end of pregnancy. Thus, sustained feedback inhibition of pituitary PRL secretion by placental lactogen would be expected (17, 20). Elevated PL, however, does not appear to inhibit the PRL secretion during the nocturnal antepartum surge (26, 27). Moreover, in rats bearing intrahypothalamic anterior pituitary grafts to induce central hyperprolactinemia, the antepartum PRL surge was unaffected (28). These observations suggest that the mechanisms involved in negative feedback regulation of PRL secretion become unresponsive during the antepartum period in the rat. A similar lack of responsiveness to PRL has been described in lactating rats (29, 30). This effect is not due to the decreased sensitivity of the lactotrophs to dopamine in the pituitary, as bromocriptine, a dopamine agonist, completely abolishes the antepartum PRL surge (28). Thus, the lack of feedback regulation is likely to be mediated by a change in the responsiveness of TIDA neurons to PRL or placental lactogen during the last days of gestation.

The few studies examining TIDA neuronal activity during late pregnancy provide evidence suggesting a gradual reduction of dopamine synthesis and secretion at this time. Dopamine levels in the portal blood showed a slight, but not significant, decrease on the day before parturition (31). Similarly, tyrosine hydroxylase messenger RNA expression in the arcuate nucleus was reduced on day 20 of pregnancy, although tyrosine hydroxylase activity at this time was not significantly different from that at other time points throughout pregnancy (11). Both of these studies, however, collected only a single sample and did not account for the nocturnal PRL surge. Hence, the present study was designed to characterize TIDA neuronal activity specifically during the antepartum PRL surge and to compare this with known changes in TIDA activity that occur during early and midpregnancy. It was hypothesized that TIDA activity would be reduced during the antepartum surge to allow elevated PRL secretion to occur.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animal preparation
Animals were obtained from the Department of Laboratory Animal Sciences, University of Otago. Mature female Sprague Dawley rats, weighing between 200–250 g, were group housed (n <= 5) in plastic cages under a 14-h light, 10-h dark cycle (lights on at 0500 h). Temperature was maintained at 22 ± 1 C, and all rats had free access to food and water. The estrous cycle was monitored by daily cytological examination of vaginal smears. Proestrous females were paired with males, and mating was confirmed by the presence of sperm in vaginal smears the following morning. This was designated day 0 of pregnancy, and parturition usually occurred on the morning of day 22 in our colony. All animal experimental protocols were approved by the University of Otago committee on ethics in the care and use of laboratory animals.

Pattern of PRL secretion during early and late pregnancy
For serial blood sampling, the right jugular vein was cannulated under ether anesthesia following the protocol of Harms and Ojeda (32). The patency of the cannulae was maintained by daily flushing with heparinized saline. For early pregnancy sample collection, cannulae were implanted on day 5 (n = 7 rats). Serial blood samples (300 µl) were collected from each rat at 0900, 1200, 1500, 1700, 1900, and 2200 h on day 6 and at 0100, 0300, 0500, and 0900 h on day 7. The underlined times represent the expected times of the diurnal and nocturnal PRL surges, respectively (6, 7, 8). Blood samples were centrifuged, and the plasma was stored at -20 C until PRL RIA. Red blood cells were resuspended in sterile saline and replaced into the rat after the subsequent sample collection. For late pregnant sample collection, cannulae were implanted on day 18 (n = 5 rats), and blood samples were taken from day 20 of gestation until the day of parturition: at 1200, 1700, and 2200 h on day 20; 0100, 0300, 0500, 0900, 1200, 1700, and 2200 h on day 21; and 0100, 0300, 0500, and 0900 h on day 22. The underlined times represent the expected time of the antepartum PRL surge (22, 26).

Estimation of TIDA activity during pregnancy
Exp 1. Groups of rats were killed by decapitation at 1200 and 0300 h on days 8 and 9 during early pregnancy and on days 21 and 22 during late pregnancy. These times were selected to represent the trough and peak time points of plasma PRL concentrations, respectively. For early pregnancy, the animals that had previously been used for serial sampling were included in the brain collection group, whereas separate groups of animals were used for the two end points during late pregnancy. Trunk blood was collected at the time of death and allowed to clot at 4 C overnight, and serum was stored at -20 C until PRL RIA. The brains were immediately frozen on dry ice and stored at -80 C until microdissection of the median eminence using the micropunch technique (33).

Exp 2. To further characterize the time course of changes during late pregnancy, Exp 1 was repeated with additional time points. Groups of animals were killed at 1200 and 0300 h on days 7 and 8, 11 and 12, 15 and 16, 19 and 20, 20 and 21, and 21 and 22 of pregnancy, respectively. Trunk blood and brain tissue were collected as described above.

Measurement of catecholamines in the median eminence
Frozen coronal brain sections (300 µm) were cut in a cryostat at -9 C, thaw-mounted onto glass slides, and refrozen. The median eminence was punched from three consecutive sections (approximately Bregma -2.30 to -3.30) (33) and placed in 50 µl tissue buffer (0.05 M Na2HPO4, 0.03 M citric acid, and 12% methanol in HPLC grade water, pH 3.0). Samples were then sonicated in an ultrasonic cell disrupter and centrifuged at 10,000 rpm for 10 min, and the supernatant was collected and stored at -20 C until measurement of catecholamines and metabolites by HPLC. The tissue pellet was dissolved in 1 N NaOH, and tissue protein content was measured using an assay kit (Bio-Rad Laboratories, Inc., Hercules, CA).

Catecholamine and metabolite concentrations were assayed by isocratic HPLC with electrochemical detection. The mobile phase, consisting of tissue buffer, containing 0.1 M EDTA and 0.15 g/liter octane sulfonic acid (pH 3.0), was pumped at a flow rate of 600 µl/min. Catecholamines were separated on a reverse phase C18 column (100 mm; Microsorb-MV, Rainin LC and Supplies, Walnut Creek, CA) and detected using a conditioning cell (+100 mV) and a dual electrode analytical cell (-150 mV and +370 mV) by a Coulochem II detector (ESA, Bedford, MA). Norepinephrine, dopamine, and 3,4-dihydroxyphenylacetic acid (DOPAC) were identified on the basis of their peak retention times (3.7, 8.4, and 10.1 min, respectively) and quantified by comparison with external standards.

RIA for PRL
Plasma or serum concentrations of PRL were measured by RIA using reagents provided by the NIDDK National Hormone and Pituitary program. Samples (20- to 100-µl aliquots) or standard preparation (rPRL-RP-3) were incubated overnight with primary antibody (anti-rPRL-S-9; final dilution, 1:490 000) and freshly iodinated rPRL-I-6 (10,000 cpm) in a total volume of 400 µl. Bound counts were precipitated by sheep antirabbit IgG and 1.5 ml 4% polyethylene glycol at 4 C, followed by centrifugation at 1,600 x g for 30 min. These conditions provided approximately 19.5% total binding, with nonspecific binding less than 2%, and a sensitivity of 1 ng/ml. The data collected from the assay were analyzed using AssayZap software for the Macintosh computer (Biosoft, Ferguson, MO). Intraassay coefficients of variance were less than 10%.

Statistical analysis
All data are presented as the mean and SEM. Plasma and serum PRL concentrations are presented as nanograms per ml. Dopamine and DOPAC concentrations in the median eminence are expressed as picograms per µg protein. Differences between groups were analyzed using one-way ANOVA, followed by Fisher’s protected least significant difference post-hoc test. The significance level for all statistics was set at P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Serial plasma PRL levels
Plasma PRL concentrations during days 7–8 of pregnancy show the diurnal and nocturnal PRL surges characteristic of early pregnancy (Fig. 1AGo). The peak of the diurnal surge was approximately 230 ng rPRL-RP-3/ml and occurred at 1700 h, whereas the peak of the nocturnal surge was approximately 260 ng rPRL-RP-3/ml and occurred at 0300 h. Between PRL surges were clear troughs of secretion, with plasma PRL falling to basal levels at 1200 and 2300 h. Plasma PRL concentrations during days 20–22 of pregnancy show the antepartum PRL surge during the last night of pregnancy (Fig. 1BGo). The surge began at approximately 1700 h on day 21 of gestation, and PRL concentrations were still high at 0900 h on day 22. The antepartum PRL surge was of similar magnitude to the surges of early pregnancy. Interestingly, the time of onset of the surge in late pregnancy rats was comparable to that of the diurnal surge in early pregnancy. Unlike the surge of early pregnancy, the initial peak of PRL during late pregnancy was not followed by a trough, and plasma PRL concentrations remained high throughout the nights of days 21–22. All rats delivered pups between 0800–1200 h on day 22 of gestation, indicating a normal duration of pregnancy in this colony.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. Mean (±SEM) plasma PRL profiles during early pregnancy (A; n = 7) and late pregnancy (B; n = 5). Each graph is aligned on the same time scale, so that a comparison of hormone profiles between early and late pregnancy can be made. Black bars along the x-axis represent the dark period of the light/dark cycle. Arrows show the times of brain collection for neurochemical assays. The range of parturition times is shown by the horizontal bar.

 
Median eminence catecholamine and metabolite concentrations
Exp 1. During early pregnancy, median eminence DOPAC levels were significantly lower at 0300 h than at 1200 h (P < 0.05; Fig. 2BGo) and were inversely related to serum PRL concentrations at the same time point (Fig. 2AGo). During late pregnancy, however, there was no apparent association between serum PRL levels and TIDA activity, as median eminence DOPAC content was low at both 1200 h on day 21 and 0300 h on day 22 compared with that at 1200 h during early pregnancy (P < 0.05; Fig. 2BGo). By contrast, there were marked differences in PRL concentrations at these two time points (Fig. 2AGo). Median eminence dopamine, like DOPAC, was also significantly reduced at 1200 and 0300 h during late pregnancy compared with that at 1200 h during early pregnancy (Fig. 2CGo). No difference was observed in dopamine concentrations between 1200–0300 h in either late or early pregnancy. Changes in catecholamines were specific to the dopaminergic neurons, as norepinephrine concentrations in the median eminence were not affected by time of day or stage of pregnancy (data not shown).



View larger version (13K):
[in this window]
[in a new window]
 
Figure 2. Mean (±SEM) serum PRL levels (A), median eminence DOPAC concentrations (B), and median eminence dopamine concentrations (C) at 1200 h ({blacksquare}) and 0300 h () during early pregnancy (1200 h on day 8; 0300 h on day 9) and late pregnancy (1200 h on day 21; 0300 h on day 22; n = 5–7/group). *, Significant difference at 0300 h compared with 1200 h at the same stage of pregnancy; {dagger}, significant difference of each time point during late pregnancy compared with 1200 h of early pregnancy; {ddagger}, significant difference compared with 0300 h during early pregnancy.

 
Exp 2. Consistent with the data from Exp 1, the noctural surge of early pregnancy was associated with a significant decrease in median eminence DOPAC concentrations, whereas DOPAC concentrations were low before and during the antepartum PRL surge (Fig. 3Go). DOPAC concentrations were consistently high during the second half of pregnancy, not significantly different from levels observed at 1200 h during early pregnancy, associated with low levels of serum PRL. DOPAC concentrations significantly decreased between 0300–1200 h on day 21, approximately 36 h before parturition. Despite this large decrease in DOPAC concentrations, there was no change in serum PRL concentrations over this time.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 3. Mean (±SEM) serum PRL levels (A) and median eminence DOPAC concentrations (B) at 1200 h ({blacksquare}) and 0300 h () at different times during pregnancy (n = 6–10 for each group). *, Significant difference compared with all unmarked times; {dagger}, significant difference compared with all unmarked times except 0300 h on day 12, 1200 h on day 15, and 1200 h on day 19.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This is the first study to examine TIDA neuronal activity during the antepartum PRL surge. During early pregnancy DOPAC levels in the median eminence showed an inverse relationship to serum PRL concentrations. This is consistent with previous data (8, 10, 11, 12, 13, 34) and demonstrates the tight association between the activity of TIDA neurons and the secretion of PRL. This association has been further emphasized by recent gene disruption experiments. Animals lacking a functional D2 receptor are hyperprolactinemic (35, 36) due to the absence of dopamine inhibition of PRL secretion. Similarly, PRL receptor-deficient mice are hyperprolactinemic (37), presumably due to the lack of PRL stimulation of TIDA neurons. The data from late pregnant animals, however, contrast markedly with those from early pregnancy. Despite the dramatic decrease in DOPAC between 0300 and 1200 h on day 21 there was no change in PRL secretion. Similarly, although DOPAC was low throughout the last 24 h of pregnancy, PRL secretion occurred as a noctural surge. These data demonstrate a dissociation of PRL secretion from TIDA activity during late pregnancy, suggesting that the reduction of dopamine inhibitory tone is not the only determinant of the antepartum PRL surge, and that other (e.g. PRL-releasing) factors may be involved.

The dopamine transporter plays an important role in regulating the amount of dopamine reaching the lactotroph, illustrated by the hypoprolactinemia observed in animals lacking the dopamine transporter (38) or after pharmacological blockade of the transporter (39). Once released from TIDA neurons a proportion of dopamine is recaptured by the dopamine transporter in the median eminence and is metabolized by mitochondrial monoamine oxidase to form DOPAC, which is then rapidly removed from the terminal. The concentration of DOPAC in the median eminence at any time, therefore, reflects current levels of dopamine metabolism within these neurons, providing an accurate index of TIDA neuronal activity (40). Although dopamine concentrations in the median eminence have been shown to be an unreliable measure of TIDA neuronal activity (40) compared with DOPAC content, we also observed changes in dopamine content in the median eminence during late pregnancy. The significant suppression of dopamine concentration observed compared with that in early pregnancy probably reflects an overall reduction in dopamine synthesis in these neurons.

The observation of a broad nocturnal PRL surge in the night preceding parturition is largely consistent with our previous description of PRL secretion during late pregnancy (22), except that in the present study the antepartum PRL surge began earlier than the previously reported 2300 h (22). This difference is likely to be due to the different strains of rat used (Sprague Dawley vs. Wistar) or the different light cycle conditions (14-h light, 10-h dark cycle vs. 12-h light, 12-h dark cycle) under which the animals were housed. In comparing the antepartum surge with the surges of early pregnancy it is apparent that the onset of the surge in the present study was similar to the onset of the diurnal surge of early pregnancy. The major difference between early and late pregnancy was the lack of a trough after the initial peak of PRL secretion during the antepartum PRL surge, which resulted in the formation of a broad peak. This may be explained by the TIDA neurons becoming less responsive to PRL or placental lactogen during late pregnancy (27, 28). During early pregnancy, it seems likely that the diurnal surge of PRL reaches a level where it would begin to stimulate the activity of the TIDA neurons. This increased dopamine tone would then inhibit further PRL release from the anterior pituitary, resulting in the trough between the two surges. During late pregnancy, however, PRL short-loop feedback becomes less effective or nonfunctional (27, 28), implying the TIDA neurons are unresponsive to PRL. This is illustrated in the present studies where, despite prolonged elevations of PRL during the night preceding parturition, TIDA neurons are not activated. Hence, there is a prolonged elevation of PRL levels in the blood during the last night of pregnancy.

These data support and extend previous studies suggesting that TIDA neuronal activity is reduced during late pregnancy compared with earlier times throughout pregnancy (11, 31). The decreased TIDA neuronal activity observed during late pregnancy correlates well with the previously reported reduction in tyrosine hydroxylase gene expression on day 20 (11). In that study, levels of TIDA activity measured neurochemically were not significantly lower on day 20 than during early and midpregnancy. This is consistent with our finding that TIDA activity acutely falls between 0300–1200 h on day 21. It seems likely that the reduction in tyrosine hydroxylase gene expression precedes measurable changes in neurotransmitter release. Interestingly, there are several reports of decreased tyrosine hydroxylase activity in TIDA neurons during lactation (41, 42). This is apparently due to the coordinated effect of suckling-induced suppression of TIDA activity (43, 44), combined with a lack of response to the stimulatory actions of PRL (29, 30). Data from the present study suggest that the decrease in TIDA activity has already occurred by the last day of pregnancy. This neuronal adaptation precedes the onset of the suckling stimulus, suggesting that it is mediated by the hormonal changes of late pregnancy.

The mechanism(s) of suppression of TIDA activity and subsequent increase in PRL secretion during late pregnancy have not been determined. The timing of the observed changes correlates with the increasing estrogen/progesterone ratio brought about by luteolysis during late pregnancy (11). We have demonstrated previously that the changes in ovarian steroids are critical for controlling the timing of the antepartum PRL surge (22). Changes in ovarian steroids during late pregnancy cause activation of the hypothalamic opioid systems (45), and endogenous opioid peptides have been implicated in regulating the antepartum PRL surge (23). Endogenous opioids are also required for the PRL surges of early pregnancy (46) and in response to suckling (43, 44) and apparently act by decreasing the activity of TIDA neurons (47, 48, 49). Hence, it is possible that activation of hypothalamic opioid pathways during late pregnancy might suppress the inhibitory dopaminergic tone and thus account for the decrease in TIDA activity observed in the present study.

The removal of dopaminergic inhibition is clearly necessary for generation of the antepartum PRL surge, as we have previously demonstrated that administration of a dopamine agonist can block this surge (28). The expected consequence of a generalized removal of the inhibitory dopamine tone at the end of pregnancy would be a concurrent increase in PRL secretion. PRL secretion, however, still occurs as a relatively discrete noctural surge. It is possible that some PRL inhibition is maintained by other neuroendocrine dopaminergic neurons via the neurointermediate lobe (2). Alternatively, the data suggest the involvement of other factors in addition to the changes in TIDA neuronal activity. One possibility is that the reduced dopamine tone during late pregnancy unmasks the endogenous stimulatory rhythm postulated to control PRL secretion (50). This would allow the surge pattern of PRL secretion seen during early pregnancy to reoccur. This hypothesis is supported by the observation that vasoactive intestinal polypeptide is involved in the regulation of both the nocturnal component of the endogenous stimulatory rhythm during early pregnancy (51, 52) and the nocturnal antepartum PRL surge (23). In the present study the antepartum PRL surge was shown to begin by 1700 h on day 21, perhaps temporally related to the endogenous diurnal surge. As described above, the lack of the normal response of TIDA neurons to elevated PRL would result in the prolonged antepartum PRL surge without exhibiting the trough that one sees between the diurnal and nocturnal peaks of early pregnancy.

In conclusion, the present study has shown that unlike early pregnancy, in which PRL secretion is tightly linked to TIDA neuronal activity, PRL secretion during late pregnancy is not closely associated with TIDA activity. Hence, the data suggest that dopamine is not the only regulator of the antepartum PRL surge. Moreover, the data provide further evidence that the lack of responsiveness of TIDA neurons to PRL during late pregnancy contributes to the maintenance of the surge. Although the mechanism controlling this adaptation is not known, it is postulated that the suppression of TIDA activity and the lack of responsiveness may be induced by activation of endogenous opioid pathways after steroid hormone changes at the end of pregnancy. The overall reduction of the inhibitory dopamine tone at the end of pregnancy may unmask an endogenous stimulatory rhythm similar to that described in early pregnancy, allowing other factors to increase PRL secretion in a discrete surge pattern. Regardless of the specific mechanism involved, the change in neuroendocrine regulation of PRL represents a physiologically important adaptation of the maternal brain, allowing a state of hyperprolactinemia that is essential for milk production (53) and maternal behavior (54).


    Acknowledgments
 
The authors thank Rob Porteous and Dr. Bruce Russell for technical assistance.


    Footnotes
 
1 This work was supported by the Health Research Council of New Zealand and the New Zealand Lottery Grants Board. Back

Received August 29, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Ben-Jonathan N 1985 Dopamine: a prolactin-inhibiting hormone. Endocr Rev 6:564–589[CrossRef][Medline]
  2. Freeman ME, Kanyicska B, Lerant A, Nagy G 2000 Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523–1631[Abstract/Free Full Text]
  3. Lerant A, Freeman ME 1998 Ovarian steroids differentially regulate the expression of PRL-R in neuroendocrine dopaminergic neuron populations: a double label confocal microscopic study. Brain Res 802:141–158[CrossRef][Medline]
  4. Arbogast LA, Voogt JL 1997 Prolactin (PRL) receptors are colocalized in dopaminergic neurons in fetal hypothalamic cell cultures: effect of PRL on tyrosine hydroxylase activity. Endocrinology 138:3016–3023[Abstract/Free Full Text]
  5. Grattan D Role of prolactin receptors in the brain during pregnancy and lactation. In: Ingram C, Russell J (eds) The Maternal Brain. Elsevier, Amsterdam, in press
  6. Butcher RL, Fugo NW, Collins WE 1972 Semicircadian rhythm in plasma levels of prolactin during early gestation in the rat. Endocrinology 90:1125–1127[Medline]
  7. Smith MS, Neill JD 1976 Termination at midpregnancy of the two daily surges of plasma prolactin initiated by mating in the rat. Endocrinology 98:696–701[Abstract]
  8. McKay DW, Pasieka CA, Moore KE, Riegle GD, Demarest KT 1982 Semicircadian rhythm of tuberoinfundibular dopamine neuronal activity during early pregnancy and pseudopregnancy in the rat. Neuroendocrinology 34:229–235[Medline]
  9. Gunnet JW, Freeman ME 1983 The mating-induced release of prolactin: a unique neuroendocrine response. Endocr Rev 4:44–61[CrossRef][Medline]
  10. De Greef WJ, Neill JD 1979 Dopamine levels in hypophysial stalk plasma of the rat during surges of prolactin secretion induced by cervical stimulation. Endocrinology 105:1093–1099[Abstract]
  11. Arbogast LA, Voogt JL 1991 Mechanisms of tyrosine hydroxylase regulation during pregnancy: evidence for protein dephosphorylation during the prolactin surges. Endocrinology 129:2575–2582[Abstract]
  12. Demarest KT, Moore KE, Riegle GD 1983 Role of prolactin feedback in the semicircadian rhythm of tuberoinfundibular dopaminergic neuronal activity during early pregnancy in the rat. Neuroendocrinology 36:371–375[Medline]
  13. Lerant A, Herman ME, Freeman ME 1996 Dopaminergic neurons of periventricular and arcuate nuclei of pseudopregnant rats: semicircadian rhythm in Fos-related antigens immunoreactivities and in dopamine concentration. Endocrinology 137:3621–3628[Abstract]
  14. Voogt JL 1980 Regulation of nocturnal prolactin surges during pregnancy in the rat. Endocrinology 106:1670–1676[Medline]
  15. Tonkowicz PA, Voogt JL 1983 Termination of prolactin surges with development of placental lactogen secretion in the pregnant rat. Endocrinology 113:1314–1318[Abstract]
  16. Voogt JL 1984 Evidence for an inhibitory influence of rat placental lactogen on prolactin release in vitro. Biol Reprod 31:141–147[Abstract]
  17. Voogt J, De Greef WJ 1989 Inhibition of nocturnal prolactin surges in the pregnant rat by incubation medium containing placental lactogen. Proc Soc Exp Biol Med 191:403–407[Abstract]
  18. Arbogast LA, Soares MJ, Tomogane H, Voogt JL 1992 A trophoblast-specific factor(s) suppresses circulating prolactin levels and increases tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons. Endocrinology 131:105–113[Abstract]
  19. Nicoll CS, Mayer GL, Russell SM 1986 Structural features of prolactins and growth hormones that can be related to their biological properties [published erratum appears in Endocr Rev 1987 Feb;8(1):43]. Endocr Rev 7:169–203[CrossRef][Medline]
  20. Demarest KT, Duda NJ, Riegle GD, Moore KE 1983 Placental lactogen mimics prolactin in activating tuberoinfundibular dopaminergic neurons. Brain Res 272:175–178[CrossRef][Medline]
  21. Voogt J, Robertson M, Friesen H 1982 Inverse relationship of prolactin and rat placental lactogen during pregnancy. Biol Reprod 26:800–805[Abstract]
  22. Grattan DR, Averill RL 1990 Effect of ovarian steroids on a nocturnal surge of prolactin secretion that precedes parturition in the rat. Endocrinology 126:1199–1205[Abstract]
  23. Grattan DR, Averill RLW 1991 Neurohormonal factors involved in the control of the nocturnal prolactin surge that precedes parturition in the rat. J Neuroendocrinol 4:167–172
  24. Klindt J, Robertson MC, Friesen HG 1982 Temporal concentrations of rat placental lactogen in the peripheral circulation. Biol Reprod 27:407–410[Abstract]
  25. Robertson MC, Owens RE, McCoshen JA, Friesen HG 1984 Ovarian factors inhibit and fetal factors stimulate the secretion of rat placental lactogen. Endocrinology 114:22–30[Abstract]
  26. Grattan DR, Averill RL 1991 Role of the placenta in the control of the ante-partum surge of prolactin in the rat. J Endocrinol 130:401–407[Abstract/Free Full Text]
  27. Fliestra RJ, Voogt JL 1997 Lactogenic hormones of the placenta and pituitary inhibit suckling-induced prolactin (PRL) release but not the ante-partum PRL surge. Proc Soc Exp Biol Med 214:258–264[Abstract]
  28. Grattan DR, Averill RLW 1995 Absence of short-loop autoregulation of prolactin during late pregnancy in the rat. Brain Res Bull 36:413–416[CrossRef][Medline]
  29. Arbogast LA, Voogt JL 1996 The responsiveness of tuberoinfundibular dopaminergic neurons to prolactin feedback is diminished between early lactation and midlactation in the rat. Endocrinology 137:47–54[Abstract]
  30. Demarest KT, McKay DW, Riegle GD, Moore KE 1983 Biochemical indices of tuberoinfundibular dopaminergic neuronal activity during lactation: a lack of response to prolactin. Neuroendocrinology 36:130–137[Medline]
  31. Ben-Jonathan N, Neill MA, Arbogast LA, Peters LL, Hoefer MT 1980 Dopamine in hypophysial portal blood: relationship to circulating prolactin in pregnant and lactating rats. Endocrinology 106:690–696[Medline]
  32. Harms PG, Ojeda SR 1974 A rapid and simple procedure for chronic cannulation of the rat jugular vein. J Appl Physiol 36:391–392[Free Full Text]
  33. Palkovits M, Brownstein MJ 1988 Maps and guide to microdissection of the rats brain. Elsevier, New York
  34. Mistry AM, Vidal G, Voogt JL 1991 Dopaminergic and serotonergic activity in the hypothalamus during early and late pregnancy. Brain Res 550:239–246[CrossRef][Medline]
  35. Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, Allen RG, Hnasko R, Ben-Jonathan N, Grandy DK, Low MJ 1997 Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19:103–113[CrossRef][Medline]
  36. Saiardi A, Bozzi Y, Baik JH, Borrelli E 1997 Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 19:115–126[CrossRef][Medline]
  37. Binart N, Helloco C, Ormandy C, Barra J, Clément-LaCroix P, Baran N, Kelly P 2000 Rescue of preimplantatory egg development in prolactin receptor-deficient mice after progesterone administration. Endocrinology 141:2691–2697[Abstract/Free Full Text]
  38. Bosse R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG 1997 Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19:127–138[CrossRef][Medline]
  39. Demaria JE, Nagy GM, Lerant AA, Fekete MI, Levenson CW, Freeman ME 2000 Dopamine transporters participate in the physiological regulation of prolactin. Endocrinology 141:366–374[Abstract/Free Full Text]
  40. Lookingland KJ, Jarry HD, Moore KE 1987 The metabolism of dopamine in the median eminence reflects the activity of tuberoinfundibular neurons. Brain Res 419:303–310[CrossRef][Medline]
  41. Li C, Chen P, Smith MS 1999 Neuropeptide Y and tuberoinfundibular dopamine activities are altered during lactation: role of prolactin. Endocrinology 140:118–123[Abstract/Free Full Text]
  42. Wang HJ, Hoffman GE, Smith MS 1993 Suppressed tyrosine hydroxylase gene expression in the tuberoinfundibular dopaminergic system during lactation. Endocrinology 133:1657–1663[Abstract]
  43. Selmanoff M, Wise PM 1981 Decreased dopamine turnover in the median eminence in response to suckling in the lactating rat. Brain Res 212:101–115[CrossRef][Medline]
  44. Selmanoff M, Gregerson KA 1985 Suckling decreases dopamine turnover in both medial and lateral aspects of the median eminence in the rat. Neurosci Lett 57:25–30[CrossRef][Medline]
  45. Douglas AJ, Johnstone H, Brunton P, Russell JA 2000 Sex-steroid induction of endogenous opioid inhibition on oxytocin secretory responses to stress. J Neuroendocrinol 12:343–350[CrossRef][Medline]
  46. Sagrillo CA, Voogt JL 1991 Endogenous opioids mediate the nocturnal prolactin surge in the pregnant rat. Endocrinology 129:925–930[Abstract]
  47. Callahan P, Baumann MH, Rabii J 1996 Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of µ and {kappa} opiate receptor subtypes. J Neuroendocrinol 8:771–776[CrossRef][Medline]
  48. Arbogast LA, Voogt JL 1998 Endogenous opioid peptides contribute to suckling-induced prolactin release by supressing tyrosine hydroxylase activity and messenger ribonucleic acid levels in tuberoinfundibular dopaminergic neurons. Endocrinology 139:2857–2862[Abstract/Free Full Text]
  49. Shieh K, Pan J 1997 Nicotinic control of tuberoinfundibular dopaminergic neuron activity and prolactin secretion: diurnal rhythm and involvement of endogenous opioidergic system. Brain Res :266–272
  50. Arey BJ, Averill RL, Freeman ME 1989 A sex-specific endogenous stimulatory rhythm regulating prolactin secretion. Endocrinology 124:119–123[Abstract]
  51. Arey BJ, Freeman ME 1989 Hypothalamic factors involved in the endogenous stimulatory rhythm regulating prolactin secretion. Endocrinology 124:878–883[Abstract]
  52. Arey BJ, Freeman ME 1990 Oxytocin, vasoactive-intestinal peptide, and serotonin regulate the mating-induced surges of prolactin secretion in the rat. Endocrinology 126:279–284[Abstract]
  53. Tucker HA 1994 Lactation and its hormonal control. In: Knobil E, JD Neill (eds) The Physiology of Reproduction. Raven Press, New York, vol 2:1065–1098
  54. Lucas BK, Ormandy CJ, Binart N, Bridges RS, Kelly PA 1998 Null mutation of the prolactin receptor gene produces a defect in maternal behavior. Endocrinology 139:4102–4107[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J EndocrinolHome page
T. Misztal, K. Gorski, D. Tomaszewska-Zaremba, E. Molik, and K. Romanowicz
Identification of salsolinol in the mediobasal hypothalamus of lactating ewes and its relation to suckling-induced prolactin and GH release
J. Endocrinol., July 1, 2008; 198(1): 83 - 89.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. J. Steyn, G. M. Anderson, and D. R. Grattan
Hormonal Regulation of Suppressors of Cytokine Signaling (SOCS) Messenger Ribonucleic Acid in the Arcuate Nucleus during Late Pregnancy
Endocrinology, June 1, 2008; 149(6): 3206 - 3214.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. A. Augustine and D. R. Grattan
Induction of Central Leptin Resistance in Hyperphagic Pseudopregnant Rats by Chronic Prolactin Infusion
Endocrinology, March 1, 2008; 149(3): 1049 - 1055.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. R Valdez, A. B Penissi, R. P Deis, and G. A Jahn
Hormonal profile and reproductive performance in lactation deficient (OFA hr/hr) and normal (Sprague-Dawley) female rats
Reproduction, April 1, 2007; 133(4): 827 - 840.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. M. Anderson, P. Beijer, A. S. Bang, M. A. Fenwick, S. J. Bunn, and D. R. Grattan
Suppression of Prolactin-Induced Signal Transducer and Activator of Transcription 5b Signaling and Induction of Suppressors of Cytokine Signaling Messenger Ribonucleic Acid in the Hypothalamic Arcuate Nucleus of the Rat during Late Pregnancy and Lactation
Endocrinology, October 1, 2006; 147(10): 4996 - 5005.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Bertram, M. Egli, N. Toporikova, and M. E. Freeman
A mathematical model for the mating-induced prolactin rhythm of female rats
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E573 - E582.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Mouihate, S. Ellis, E.-M. Harre, and Q. J. Pittman
Fever suppression in near-term pregnant rats is dissociated from LPS-activated signaling pathways
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1265 - R1272.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Vaillant, F. Chesnel, D. Schausi, C. Tiffoche, and M.-L. Thieulant
Expression of Estrogen Receptor Subtypes in Rat Pituitary Gland during Pregnancy and Lactation
Endocrinology, November 1, 2002; 143(11): 4249 - 4258.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrews, Z. B.
Right arrow Articles by Grattan, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrews, Z. B.
Right arrow Articles by Grattan, D. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals